<DOC>
	<DOCNO>NCT02643784</DOCNO>
	<brief_summary>This exploratory , randomize , open-label , 2-arm , parallel-group study explore efficacy rosuvastatin ( 20mg/day ) patient acute ischemic stroke .</brief_summary>
	<brief_title>Exploratory Study Effects Early Rosuvastatin Treatment Patients With Acute Ischemic Stroke</brief_title>
	<detailed_description>This 90-day , explanatory ; randomize ; open-label , 2-arm ; parallel group blind outcome evaluation study explore efficacy study early rosuvastatin 20 mg/d treatment acute ischemic patient stroke onset 24 hour .</detailed_description>
	<mesh_term>Ischemia</mesh_term>
	<mesh_term>Rosuvastatin Calcium</mesh_term>
	<criteria>1 . 45 75 year old patient ; 2 . Stroke involve vascular territory middle cerebral artery ( MCA ) judge clinical MRI evidence ; 3 . Time symptom onset take study assign medication within 24 hour ; 4 . Statin naïve discontinue least 3 month stroke onset ; 5 . First ever stroke mild sequela ( modify Rankin Score 01 ) index event ; 6 . Moderate neurological deficit baseline NIHSS score 420 ; 7 . MRI scan （T1W1、T2W2、T2Flair、DWI、SWI）accomplished 12 48 hour onset ; 8 . Consent form sign . Any follow regarded criterion exclusion study : 1 . Stroke involve vascular territory vertebrobasilar artery judge clinical MRI evidence ; 2 . Hemorrhagic transformation intracranial hemorrhage baseline MRI . MRI perform 1248 hour onset , MRI provide evidence meet exclusion criterion , patient exclude study ; 3 . Any circumstance MRI scan ca n't perform ; 4 . Evidences suggest cardiogenic stroke atrial fibrillation , acute coronary syndrome , patent foramen ovale , etc ; 5 . Comatose NIHSS 1a &gt; 1 ; 6 . Medical psychiatric condition severe hepatic renal dysfunction , heart failure , malignancy , major depression , dementia , alcohol drug abuse ; 7 . Suitable rtPlasminogen Activator thrombolysis treatment ; 8 . Receiving medication possible neuroprotective function stroke onset ; 9 . Currently take steroid therapy ; 10 . Diagnosed malignancy within 5 year ; 11 . Patients myopathy serum creatine kinase &gt; 3 time upper limit normal cause myocardial injury ; 12 . Severe renal function damage ( eGFR &lt; 30 ) ; 13 . Concurrent use ciclosporin ; 14 . A history hypersensitivity statins severe complication ; 15 . Childbearing woman ; 16 . Patients may pregnant ; 17 . Other condition patient pertinent attend study judge investigator .</criteria>
	<gender>All</gender>
	<minimum_age>45 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>December 2015</verification_date>
	<keyword>acute ischemic stroke</keyword>
</DOC>